Key result
Drug therapy problems linked to ~265% higher in-hospital mortality risk among heart failure patients.
Why the study?
Heart failure is a major global health problem leading to mortality, prompting this evaluation of treatment outcomes and associated factors in hospitalized patients in southwest Ethiopia.
What are the prevalence and risk factors of in-hospital mortality among heart failure patients in low-resource setting hospitals?
Observational (n=241)
Yes
What are the prevalence and risk factors of in-hospital mortality among heart failure patients in low-resource setting hospitals?
Effect estimate: AOR 3.65 (95% CI 1.13-11.73)
Absolute Event Rate: 18.8% vs 6.6%
p-value: p=0.03
In a low-resource setting in Ethiopia, in-hospital mortality for heart failure is high (14.9%) and is strongly predicted by older age, prior hospitalization, and drug therapy problems.
Drug therapy problems were associated with higher HF in-hospital mortality; hypothesis-generating for medication optimization trials in low-resource settings.
Background Heart failure is a significant worldwide health problem that leads to mortality. Therefore, this study aimed to evaluate treatment outcomes and associated factors of heart failure patients who were admitted to hospitals in the southwest of Ethiopia. Methods and participants A multicenter prospective observational study was conducted from 1 February to 1 August 2021. Drug therapy problems were assessed as per the Cipolle, Strands, and Morley drug therapy problems classification method. The drug therapy was registered by using the drug-related problem registration format. The results of logistic regression analysis was interpreted as crude odds ratio and adjusted odds ratio (AOR) at 95% confidence interval (CI) to determine the association between dependent and independent variables. Results In our study settings, a total of 205 (85.1%) heart failure patients showed improvement and 36 (14.9%) died at hospital discharge. Being ≥65 years (AOR = 7.14, 95% CI: 2.04–.25.01, P = 0.002), a previous hospitalization (AOR = 6.20, 95% CI: 1.81–21.21, P = 0.004), and the presence of medication-related problems (AOR = 3.65, 95% CI: 1.13–11.73, P = 0.03) were the predictors of mortality. Conclusion The prevalence of in-hospital mortality among heart failure patients was found to be high. Previous hospitalization, older age, and the presence of drug therapy problems were the predictors of mortality among heart failure patients. Therefore, proper attention should be given to the management of elderly and re-admitted heart failure patients in addition to their regular care. In addition, hospitals should implement clinical pharmacy services to address any drug-related problems.
No takes yet. Share an insight, caveat, or question.
Bekele et al. (2024) conducted an observational in Heart failure (n=241). Drug therapy problems vs. No drug therapy problems was evaluated on In-hospital mortality (AOR 3.65, 95% CI 1.13-11.73, p=0.03). The presence of drug therapy problems significantly increased the risk of in-hospital mortality among heart failure patients (AOR 3.65) compared to those without medication-related issues.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: